Kickstarting Drug Discovery With CRISPR

Researchers exploit the power of genome editing technologies to find better therapeutic targets. 

Drug development starts with target discovery, a process that involves identifying gene targets linked to a disease and assessing target-disease relationships. With the CRISPR-based genome editing system, scientists can simultaneously manipulate, screen, and functionally characterize thousands of genes to identify promising drug targets.

Download this ebook from Synthego to learn how to use CRISPR screening to uncover and validate therapeutic targets for increased drug discovery success.

Sponsored by